Forty-two small-cap proxies name a compensation committee. None of them name a chair.

Somewhere in your proxy statement is a sentence that says who chairs your compensation committee. It’s usually one clause, easy to skim past, sitting between the committee’s charter language and its meeting count for the year. Most companies get it right without thinking about it.

We went looking for the ones that don’t. Across a coverage universe of 977 U.S. operating companies under $300 million in market value, we pulled the compensation committee section of the most recent DEF 14A for each one. 834 name a chair. Of the rest, a good number simply don’t have a standing compensation committee at all — closed-end funds, controlled companies leaning on the Nasdaq exemption, a few that fold the function into the full board. Those are deliberate governance choices, disclosed as such, and not what this is about.

Forty-two are different. Forty-two proxies name the members of a compensation committee — two, three, sometimes four directors, listed by name — and then simply don’t say which one runs it. No chair designation in the committee table, none in the narrative, none in the compensation committee report. The members exist. The org chart for that one committee doesn’t.

Some of these are legacy filings that never got cleaned up: a chair left the board, or passed away mid-cycle, and the next proxy quietly dropped the title along with the name rather than reassigning it. A few are companies where the committee genuinely operates as co-equals and no one has bothered to formalize a chair, because nothing has forced the question yet. Either way, the effect on a reader — a proxy advisor, an institutional holder, a plaintiff’s firm doing diligence before a say-on-pay challenge — is the same. There’s no name to hold accountable for how the committee ran its process this year.

Why a proxy advisor cares about a title, not a person

ISS and Glass Lewis don’t evaluate your compensation committee as a group of individually excellent directors. They evaluate the process, and the chair is the process’s single point of accountability — the person whose name goes on the narrative when a pay decision gets questioned, and the person both firms assume set the agenda when they’re deciding whether to recommend against a pay package or against a director’s re-election. Take the chair off the page and you haven’t made the committee more collegial. You’ve made it harder for anyone external to say who was responsible for the calls the committee made.

That matters more in a year when say-on-pay support is already soft somewhere in your peer set. A committee with an unclear chair reads, to a proxy advisor doing pattern matching across hundreds of filings in a six-week window, as a committee that hasn’t been forced to defend itself yet. It’s a small thing. It is also exactly the kind of small thing that shows up in an ISS QualityScore factor or a Glass Lewis governance flag as “committee structure and composition — unclear.”

None of the forty-two we found are doing anything disclosed as improper. This isn’t a fraud story. It’s a housekeeping gap that happens to sit at the one spot in the proxy where a reader is trained to look for a name, and doesn’t find one.

The fix costs nothing and usually gets skipped anyway

Naming a chair doesn’t require restructuring the committee, and it doesn’t require a board vote most companies haven’t already effectively taken — in practice, most of these committees already have someone who runs the meetings, sets the agenda, and signs off on the comp consultant’s engagement letter. The gap is almost always disclosure, not governance. Someone assumed the charter covered it, or assumed last year’s proxy language would carry forward, and it didn’t get checked before the filing went out.

It’s worth a five-minute check against your own committee charter and your last two proxies: does the current one name a chair in the same place the previous one did? If a chair changed, retired, or rotated off, did the new proxy pick up the name, or does it just list members and move on? Worth checking the reverse too — a proxy that still lists someone as chair a year after they rotated off the committee entirely is its own kind of inconsistency, and proxy advisors cross-reference committee tables against director bios more often than filers expect. The check is cheap either way. The alternative is a proxy advisor’s algorithm flagging you for something a single sentence would have fixed.

The same read applies one level down from the chair question, too. Committee composition changes — a director rotating off, a new appointee, someone stepping in mid-cycle after a departure — are the kind of detail that’s easy to update in the bio section and easy to forget in the committee table three pages later. A proxy that’s internally inconsistent about who sits where reads worse to an outside advisor than one that’s simply thin on disclosure.

We built this list the same way we build the peer sets in our benchmarking reports — reading actual proxy language company by company, not running a keyword match against a data vendor’s tagged fields, which is exactly the kind of thing that misses “members are X, Y, and Z” sitting three lines above a blank chair field. If you want to know how your own committee’s disclosure reads next to companies your size, that’s the same lens a $1,500 Core report runs against your own filing.